A detailed history of Hantz Financial Services, Inc. transactions in Xencor Inc stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 1,031 shares of XNCR stock, worth $12,784. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,031
Previous 11 9272.73%
Holding current value
$12,784
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 04, 2025

BUY
$7.52 - $11.26 $7,670 - $11,485
1,020 Added 9272.73%
1,031 $8,000
Q1 2025

May 12, 2025

BUY
$10.64 - $24.13 $117 - $265
11 New
11 $0

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $740M
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.